A detailed history of Centiva Capital, LP transactions in Sanofi stock. As of the latest transaction made, Centiva Capital, LP holds 12,537 shares of SNY stock, worth $649,165. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,537
Previous 20,807 39.75%
Holding current value
$649,165
Previous $1.01 Million 41.19%
% of portfolio
0.01%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$45.07 - $51.35 $372,728 - $424,664
-8,270 Reduced 39.75%
12,537 $591,000
Q2 2025

Aug 13, 2025

BUY
$47.62 - $55.44 $990,829 - $1.15 Million
20,807 New
20,807 $1.01 Million
Q4 2023

Feb 14, 2024

BUY
$43.13 - $54.79 $263,049 - $334,164
6,099 Added 109.52%
11,668 $580,000
Q3 2023

Nov 14, 2023

SELL
$50.95 - $55.2 $226,167 - $245,032
-4,439 Reduced 44.35%
5,569 $298,000
Q2 2023

Aug 14, 2023

BUY
$50.45 - $57.18 $504,903 - $572,257
10,008 New
10,008 $539,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $130B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.